CV Sciences (CVSI) Cash & Equivalents (2010 - 2026)

CV Sciences has disclosed Cash & Equivalents across 17 years of filings, most recently posting $266000.0 for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 69.98% year-over-year to $266000.0; the TTM figure through Jun 2026 stood at $266000.0 (down 69.98% YoY), while the FY2025 annual figure was $278000.0, down 38.77% from the prior year.
• Cash & Equivalents came in at $266000.0 for Q2 2026 at CV Sciences, down from $309000.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.4 million in Q1 2022 to a low of $266000.0 in Q2 2026.
• Average Cash & Equivalents over 5 years is $898388.9, with a median of $763000.0 recorded in 2023.
• Year-over-year, Cash & Equivalents jumped 115.55% in 2023 and plunged 71.78% in 2024.
• Over 5 years, Cash & Equivalents stood at $611000.0 in 2022, then jumped by 115.55% to $1.3 million in 2023, then slumped by 65.53% to $454000.0 in 2024, then tumbled by 38.77% to $278000.0 in 2025, then retreated by 4.32% to $266000.0 in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $266000.0 in Q2 2026, $309000.0 in Q1 2026, and $278000.0 in Q4 2025.